NFHealthEconomics

• 17th Apr 2024

  Value assessment of advanced therapies: improving patient access to innovative treatments

• 28th Feb 2024

  Should the value of advanced therapies fall under a subjective or objective category? Brief philosophical musings. 

• 30th Jan 2024

  Assessing the value of advanced therapies

• 1st Sep 2022

  Key Questions on the Development of Health Economics

• 12th Apr 2022

  Brief considerations on the value assessment of advanced therapy medicinal products

• 5th Sep 2021

  The potential misnomer of health economics and outcomes research

• 25th Jul 2021

  A (brief) consideration of the lack of standardisation in health economics

• 6th Feb 2021

  How should value in healthcare be defined?

• 27th Dec 2020

  The need for pragmatic updates to the NICE methods

• 20th Jul 2020

  Should health interventions be assessed only for their cost-effectiveness?

• 3rd May 2020

  How should the most relevant and appropriate health outcomes for cost-effectiveness analysis be determined?

• 20th Apr 2020

  The need for alternative data sources in cost-effectiveness analysis in health economics

• 20th Apr 2020

  Thoughts on a universal health economic data source

• 20th Apr 2020

  Should clinical trials include economic endpoints?